Wolverine Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.1M | Buy |
1,722,400
+184,700
| +12% | +$4.56M | 0.03% | 374 |
|
|
2025
Q2 | $37.2M | Buy |
1,537,700
+92,800
| +6% | +$2.16M | 0.04% | 297 |
|
|
2025
Q1 | $36.4M | Sell |
1,444,900
-92,800
| -6% | -$2.43M | 0.04% | 271 |
|
|
2024
Q4 | $40.6M | Buy |
1,537,700
+392,400
| +34% | +$10.6M | 0.04% | 280 |
|
|
2024
Q3 | $33.3M | Buy |
1,145,300
+133,200
| +13% | +$3.89M | 0.04% | 300 |
|
|
2024
Q2 | $28.3M | Sell |
1,012,100
-21,900
| -2% | -$603K | 0.03% | 312 |
|
|
2024
Q1 | $28.7M | Sell |
1,034,000
-179,800
| -15% | -$4.99M | 0.03% | 320 |
|
|
2023
Q4 | $34.9M | Buy |
1,213,800
+316,700
| +35% | +$9.57M | 0.04% | 293 |
|
|
2023
Q3 | $29.8M | Buy |
897,100
+189,700
| +27% | +$6.71M | 0.03% | 264 |
|
|
2023
Q2 | $25.6M | Sell |
707,400
-160,900
| -19% | -$6.26M | 0.03% | 301 |
|
|
2023
Q1 | $35.1M | Buy |
+868,300
| New | +$37.5M | 0.05% | 222 |
|
|
2022
Q4 | – | Sell |
-1,170,400
| Closed | -$51.7M | – | 4784 |
|
|
2022
Q3 | $51.7M | Buy |
1,170,400
+153,300
| +15% | +$7.45M | 0.08% | 133 |
|
|
2022
Q2 | $51.8M | Sell |
1,017,100
-115,600
| -10% | -$5.89M | 0.09% | 115 |
|
|
2022
Q1 | $59.4M | Sell |
1,132,700
-708,100
| -38% | -$36.7M | 0.08% | 147 |
|
|
2021
Q4 | $108M | Buy |
1,840,800
+278,500
| +18% | +$13.8M | 0.13% | 95 |
|
|
2021
Q3 | $68M | Buy |
1,562,300
+384,400
| +33% | +$17M | 0.08% | 171 |
|
|
2021
Q2 | $46.1M | Buy |
1,177,900
+463,400
| +65% | +$18M | 0.07% | 199 |
|
|
2021
Q1 | $25.8M | Sell |
714,500
-391,900
| -35% | -$13.9M | 0.04% | 315 |
|
|
2020
Q4 | $40.6M | Buy |
1,106,400
+330,656
| +43% | +$12.1M | 0.06% | 201 |
|
|
2020
Q3 | $26.6M | Buy |
775,744
+295,647
| +62% | +$10.4M | 0.06% | 223 |
|
|
2020
Q2 | $14.9M | Buy |
480,097
+171,486
| +56% | +$5.83M | 0.04% | 335 |
|
|
2020
Q1 | $9.57M | Sell |
308,611
-326,002
| -51% | -$11.1M | 0.03% | 448 |
|
|
2019
Q4 | $23.4M | Buy |
634,613
+130,801
| +26% | +$4.66M | 0.06% | 304 |
|
|
2019
Q3 | $17.3M | Sell |
503,812
-83,582
| -14% | -$3.04M | 0.05% | 327 |
|
|
2019
Q2 | $24.1M | Sell |
587,394
-149,352
| -20% | -$5.93M | 0.07% | 238 |
|
|
2019
Q1 | $29.7M | Buy |
736,746
+66,191
| +10% | +$2.65M | 0.09% | 172 |
|
|
2018
Q4 | $27.3M | Sell |
670,555
-268,559
| -29% | -$11.1M | 0.08% | 178 |
|
|
2018
Q3 | $39.3M | Buy |
939,114
+408,636
| +77% | +$15.7M | 0.09% | 140 |
|
|
2018
Q2 | $17.9M | Hold |
530,478
| – | – | 0.04% | 286 |
|
|
2018
Q1 | $17.9M | Buy |
530,478
+82,739
| +18% | +$2.84M | 0.04% | 286 |
|
|
2017
Q4 | $15.4M | Sell |
447,739
-8,432
| -2% | -$288K | 0.06% | 325 |
|
|
2017
Q3 | $15.5M | Buy |
456,171
+184,134
| +68% | +$5.92M | 0.06% | 277 |
|
|
2017
Q2 | $8.68M | Sell |
272,037
-140,288
| -34% | -$4.42M | 0.04% | 423 |
|
|
2017
Q1 | $13.4M | Sell |
412,325
-12,226
| -3% | -$385K | 0.07% | 276 |
|
|
2016
Q4 | $13.1M | Sell |
424,551
-55,651
| -12% | -$1.7M | 0.06% | 306 |
|
|
2016
Q3 | $15.2M | Buy |
+480,202
| New | +$16.1M | 0.07% | 308 |
|
Other funds holding PFE
Wolverine Trading's PFE Position: Q3 2025 in Review
Wolverine Trading reduced its Pfizer (PFE) stake by 13% in Q3 2025, selling an estimated $275K and leaving 76,642 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
Wolverine Trading first reported a position in PFE in Q3 2016 and has held it in 34 quarters since. The position peaked at $17.6M in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Wolverine Trading held 76,642 shares of Pfizer worth $1.83M as of Q3 2025.
- Wolverine Trading sold 11,126 Pfizer shares in Q3 2025, an estimated $275K.
- Pfizer made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2259 holding.
- Wolverine Trading first reported a position in Pfizer in Q3 2016 and has held it in 34 quarters since.
- Wolverine Trading's Pfizer position peaked at $17.6M in Q4 2019.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.